Trial · NCT07883343
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Feasibility outcome: Community health events | From enrollment to end of study data collection at 8 months. | The number of community health events that occurred. |
| Primary | Feasibility outcome: Health screenings at community health events | From enrollment to end of study data collection at 8 months. | The number of individual health screenings that were conducted at the community health events. |
| Primary | Feasibility outcome: Recruitment Rate | From enrollment to 6 months. | The percent of individuals identified with type 2 diabetes from the health screenings that were recruited to receive MNT. |
| Primary | Feasibility outcome: Retention rate | From enrollment to end of study data collection at 8 months. | The number of individuals who completed the MNT interventions and follow up health screen. |
| Primary | Feasibility outcome: Adherence rate | From enrollment to end of MNT provision at 3 months. | The participant rate of adherence to MNT. |
| Secondary | Behavior outcome: Dietary intake | From enrollment to end of MNT at 3 months. | Dietary intake was collected using a 24 hour recall. |
| Secondary | Behavior outcome: Physical Activity | From enrollment to end of MNT at 3 months. | Physical activity was collected using a 7-day record. |
| Secondary | Health outcome: Height | From enrollment to end of study data collection at 8 months. | Height was self reported in inches. |
| Secondary | Health outcome: Weight | From enrollment to end of study data collection at 8 months. | Body weight (lbs) was measured using digital scale. |
| Secondary | Health outcome: Blood glucose | From enrollment to end of study data collection at 8 months. | Non fasting blood glucose (mg/dL) was measured by point of care instrument. |
| Secondary | Health outcome: HbA1c | From enrollment to end of study data collection at 8 months. | HbA1c (%) was calculated using non-fasting blood glucose. |
| Secondary | Health outcome: Blood lipids | From enrollment to end of study data collection at 8 months. | Non fasting total, HDL, LDL cholesterol, triglycerides were measured by point of care instrument (mg/dL). |
| Secondary | Health outcome: Blood pressure | From enrollment to end of study data collection at 8 months. | Blood pressure was measured by digital sphygmomanometer. |
| Secondary | Health outcome: Waist circumference | From enrollment to end of study data collection at 8 months. | Waist circumference (in) was assessed with tape measure. |
| Secondary | Health outcome: BMI | From enrollment to end of study data collection at 8 months. | BMI was calculated from height and weight. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07883343/registered